High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study

International Journal of Geriatric Psychiatry

Volumn 31, Issue 8, 2016, Pages 920-928

  Yasuno, Fumihiko ^a,c   Kazui, Hiroaki ^b   Morita, Naomi ^c   Kajimoto, Katsufumi ^c   Ihara, Masafumi ^c   Taguchi, Akihiko ^c,d   Yamamoto, Akihide ^c   Matsuoka, Kiwamu ^a   Kosaka, Jun ^a   Kudo, Takashi ^e   Iida, Hidehiro ^c   Kishimoto, Toshifumi ^a   Nagatsuka, Kazuyuki ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

11C labeled Pittsburgh Compound B ( 11C PIB); Alzheimer's disease (AD); amyloid (A ); depressive symptoms; positron emission tomography (PET); precuneus posterior cingulate cortex (PCu PCC)

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

AGED; AMYLOID BETA DEPOSITION; AMYLOID NEUROPATHY; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EMOTIONAL DISORDER; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; MALE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; UPREGULATION;

EID: 84977616009     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4409     Document Type: Article

References (55)

1. Adolphs R. 2003. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 4: 165–178.
2. Baba H, Nakano Y, Maeshima H, et al. 2012. Metabolism of amyloid-beta protein may be affected in depression. J Clin Psychiatry 73: 115–120.
3. Barnes DE, Yaffe K, Byers AL, et al. 2012. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69: 493–498.
4. Bennett S, Thomas AJ. 2014. Depression and dementia: cause, consequence or coincidence? Maturitas 79: 184–190.
5. Blasko I, Kemmler G, Jungwirth S, et al. 2010. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease. Am J Geriatr Psychiatry 18: 973–982.
6. Bourgeat P, Chetelat G, Villemagne VL, et al. 2010. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74: 121–127.
7. Busche MA, Eichhoff G, Adelsberger H, et al. 2008. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321: 1686–1689.
8. Chetelat G, Villemagne VL, Pike KE, et al. 2011. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain 134: 798–807.
9. Dickerson BC, Stoub TR, Shah RC, et al. 2011. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76: 1395–1402.
10. Dubois B, Slachevsky A, Litvan I, Pillon B. 2000. The FAB: a Frontal Assessment Battery at bedside. Neurology 55: 1621–1626.
11. Eurelings LS, Richard E, Eikelenboom P, van Gool WA, Moll van Charante EP. 2015. Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals. Int Psychogeriatr 27: 639–647.
12. Fang Z, Zhu S, Gillihan SJ, et al. 2013. Serotonin transporter genotype modulates functional connectivity between amygdala and PCC/PCu during mood recovery. Front Hum Neurosci 7: 704.
13. Folstein MF, Folstein SE, McHugh PR. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189–198.
14. Gotlib IH, Joormann J. 2010. Cognition and depression: current status and future directions. Annu Rev Clin Psychol 6: 285–312.
15. Hoffman EJ, Huang SC, Phelps ME. 1979. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 3: 299–308.
16. Hsiao JJ, Teng E. 2013. Depressive symptoms in clinical and incipient Alzheimer's disease. Neurodegener Dis Manag 3: 147–155.
17. Innis RB, Cunningham VJ, Delforge J, et al. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533–1539.
18. Klunk WE, Engler H, Nordberg A, et al. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: 306–319.
19. Kukull WA, Larson EB, Teri L, et al. 1994. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J Clin Epidemiol 47: 1061–1067.
20. Lesher EL, Berryhill JS. 1994. Validation of the Geriatric Depression Scale—Short Form among inpatients. J Clin Psychol 50: 256–260.
21. Ligthart SA, Richard E, Fransen NL, et al. 2012. Association of vascular factors with apathy in community-dwelling elderly individuals. Arch Gen Psychiatry 69: 636–642.
22. Logan J, Fowler JS, Volkow ND, et al. 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834–840.
23. Ludvigsson M, Marcusson J, Wressle E, Milberg A. 2015. Markers of subsyndromal depression in very old persons. Int J Geriatr Psychiatry. doi: 10.1002/gps.4369. [Epub ahead of print].
24. Lyness JM, Heo M, Datto CJ, et al. 2006. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 144: 496–504.
25. Müller-Gärtner HW, Links JM, Prince JL, et al. 1992. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 12: 571–583.
26. Maddock RJ, Garrett AS, Buonocore MH. 2003. Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task. Hum Brain Mapp 18: 30–41.
27. Mayberg HS, Lozano AM, Voon V, et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–660.
28. McClure EB, Monk CS, Nelson EE, et al. 2007. Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 64: 97–106.
29. Modrego PJ, Ferrandez J. 2004. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 61: 1290–1293.
30. Mori T, Shimada H, Shinotoh H, et al. 2014. Apathy correlates with prefrontal amyloid beta deposition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 85: 449–455.
31. Mormino EC, Kluth JT, Madison CM, et al. 2009. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132: 1310–1323.
32. Namekawa Y, Baba H, Maeshima H, et al. 2013. Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Abeta protein metabolism. Prog Neuropsychopharmacol Biol Psychiatry 43: 203–208.
33. Otsubo T, Tanaka K, Koda R, et al. 2005. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 59: 517–526.
34. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. 2006. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530–538.
35. Palmer K, Berger AK, Monastero R, et al. 2007. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68: 1596–1602.
36. Partington JE, Leiter RG. 1949. Partington's pathway test. Psychol Serv Cent Bull 1: 9–20.
37. Pomara N, Bruno D, Sarreal AS, et al. 2012. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 169: 523–530.
38. Pomara N, Murali Doraiswamy P. 2003. Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression? Med Hypotheses 60: 640–643.
39. Pomara N, Sidtis JJ. 2010. Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets. Br J Pharmacol 161: 768–770.
40. Quigley H, Colloby SJ, O'Brien JT. 2011. PET imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry 26: 991–999.
41. Rapp MA, Schnaider-Beeri M, Grossman HT, et al. 2006. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 63: 161–167.
42. Raven JC. 1958. Guide to the Standard Progressive Matrices. HK Lewis: London.
43. Rosen WG, Mohs RC, Davis KL. 1984. A new rating scale for Alzheimer's disease. Am J Psychiatry 141: 1356–1364.
44. Rowe CC, Ellis KA, Rimajova M, et al. 2010. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31: 1275–1283.
45. Rushing NC, Sachs-Ericsson N, Steffens DC. 2014. Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 21: 99–128.
46. Scheltens P, Barkhof F, Leys D, et al. 1993. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7–12.
47. Sheehan DV, Lecrubier Y, Sheehan KH, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22–33.
48. Storandt M, Mintun MA, Head D, Morris JC. 2009. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 66: 1476–1481.
49. Sun X, Chiu CC, Liebson E, et al. 2009. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele. Alzheimer Dis Assoc Disord 23: 238–244.
50. Sun X, Steffens DC, Au R, et al. 2008. Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 65: 542–550.
51. Wechsler D. 1987. Wechsler Memory Scale—Revised. Harcourt Brace Jovanovich: San Antonio.
52. Wright P, Albarracin D, Brown RD, et al. 2008. Dissociated responses in the amygdala and orbitofrontal cortex to bottom-up and top-down components of emotional evaluation. Neuroimage 39: 894–902.
53. Wu KY, Hsiao IT, Chen CS, et al. 2014. Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging 41: 714–722.
54. Yasuno F, Hasnine AH, Suhara T, et al. 2002. Template-based method for multiple volumes of interest of human brain PET images. Neuroimage 16: 577–586.
55. Yasuno F, Kazui H, Morita N, et al. 2015. Low amyloid-beta deposition correlates with high education in cognitively normal older adults: a pilot study. Int J Geriatr Psychiatry 30: 919–926.